Latest Earnings Results: Q3 '26
Estimated EPS
$1.66
Reported EPS
$15.72
Surprise
+847.15%
Estimated Rev
$1.43B
Reported Rev
$1.46B
Surprise
+2.05%
• Reported GAAP EPS of $16.26 up 409.72% YoY • Reported revenue of $1.46B up 16.74% YoY • Alnylam targets, through its Alnylam 2030 strategy, 25%+ total revenue compound annual growth rate and approximately 30% non-GAAP operating margin through year-end 2030, while investing approximately 30% of revenues in non-GAAP R&D.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | $1.72 | -- | -- | N/A |
Q3 '26 | $1.66 | $15.72 | 847.15% | BEAT |
Q2 '26 | $1.63 | $1.21 | -25.78% | MISSED |
Q1 '26 | $0.89 | $1.51 | 68.72% | BEAT |
Q4 '25 | $1.16 | $0.82 | -29.06% | MISSED |